Summary
Updated Aug 30, 2026
Dana Yaacov-Garbeli is Chief Financial Officer of Entera Bio Ltd. (ENTX). 3 SEC Form 4 filings on record going back to 2025, most recently on 7 August 2026.
Recent Transactions
2Every recent SEC Form 4 transaction Dana Yaacov-Garbeli has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Dana Yaacov-Garbeli files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Geno J. Germano - $56K of ENTX open-market activity in the last 12 months
- Sean Ellis - $35K of ENTX open-market activity in the last 12 months
- Miranda Jayne Toledano - $20K of ENTX open-market activity in the last 12 months
- Steven D. Rubin - $19K of ENTX open-market activity in the last 12 months
- Haya Taitel - $11K of ENTX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Dana Yaacov-Garbeli?
Dana Yaacov-Garbeli is a corporate insider, tracked as Chief Financial Officer of Entera Bio Ltd. (ENTX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Dana Yaacov-Garbeli submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Dana Yaacov-Garbeli's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Dana Yaacov-Garbeli and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
